A possible link between TIMP-1 induction and response to infliximab
Derer, S.; Waetzig, G.H.; Seegert, D.; Nikolaus, S.; Schreiber, S.; Rosenstiel, P.
Gut 58(6): 888; Author Reply 888-9
2009
ISSN/ISBN: 0017-5749 PMID: 19433609 Document Number: 631411
Document emailed within 1 workday
Related Documents
Grabiec, M.; Szymański, W.; Szymański, M.; Jendryczka, J.; Polak, G.; Gogacz, M.; Rechberger, T. 2001: Concentrations of MMP-1, TIMP-1, MMP-1/TIMP-1 and i CTP complexes in follicular fluid as related to fertilization rate in women treated with in-vitro fertilization Ginekologia Polska 72(3): 107-112Allanore, Y.; Sellam, J.; Batteux, F.; Job Deslandre, C.; Weill, B.; Kahan, A. 2004: Induction of autoantibodies in refractory rheumatoid arthritis treated by infliximab Clinical and Experimental Rheumatology 22(6): 756-758
Xing, X-qian.; Xu, J.; Lü, X-wen.; Huang, Y.; Zhu, P-li. 2009: Effects of losartan and simvastatin on collagen content, myocardial expression of MMP-2 mRNA, MMP-9 mRNA and TIMP-1 mRNA, TIMP-2 mRNA in pressure overload rat hearts Zhonghua Xin Xue Guan Bing Za Zhi 37(10): 887-891
Malaviya, R.; Sun, Y.; Tan, J.K.; Magliocco, M.; Gottlieb, A.B. 2006: Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis Journal of Drugs in Dermatology: Jdd 5(9): 890-893
Szychta, M.; Wiernicka, A.; Dądalski, M.; Landowski, P.; Klincewicz, B.; Karolewska-Bochenek, K.; Czaja-Bulsa, G.ży.; Jarocka-Cyrta, E.; Korczowski, B.; Sladek, M.; Kierkus, J. 2016: Assessment of induction therapy with infliximab in children with moderate to severe ulcerative colitis: a multi-center study Developmental Period Medicine 20(3): 205-211
Luna-Chadid, M.; Pérez Calle, J.L.; Mendoza, J.L.; Vera, M.I.; Bermejo, A.F.; Sánchez, F.; López San Román, A.; Froilán, C.; González-Lara, V.; García-Paredes, J.; Fernández-Blanco, I.; Abreu, L.; Casis, B.; Solís Herruzo, J.A.; Gisbert, J.P.; Maté Jiménez, J. 2004: Predictors of response to infliximab in patients with fistulizing Crohn's disease Revista Espanola de Enfermedades Digestivas: Organo Oficial de la Sociedad Espanola de Patologia Digestiva 96(6): 379-81; 382-4
Ferkolj, I.; Ihan, A.; Markovic, S. 2005: CD19+ in intestinal mucosa predict the response to infliximab in Crohn's disease Hepato-Gastroenterology 52(64): 1128-1133
Stone, M.; Salonen, D.; Lax, M.; Payne, U.; Lapp, V.; Inman, R. 2001: Clinical and imaging correlates of response to treatment with infliximab in patients with ankylosing spondylitis Journal of Rheumatology 28(7): 1605-1614
Primieri, P.; Bonomo, V.; Adducci, E.; Bosco, M.; de Cosmo, G.; Villani, A. 1991: Comparison of the hemodynamic response to anesthesia induction with 3 different induction agents (thiopental, midazolam, and propofol) in candidates for vascular surgery Minerva Anestesiologica 57(9): 626-627
Cannioto, Z.; Taddio, A.; Lepore, L.; Zennaro, F. 2008: Atlanto-axial subluxation in a patient with polyarticular juvenile idiopathic arthritis: clinical and radiological response to infliximab Clinical and Experimental Rheumatology 26(4): 704-705
Herman, R.; Sładek, M.łg.; Pieczarkowski, S.ła.; Dumnicka, P.; Fyderek, K. 2017: Is mean platelet volume a good predictor of sustained response to one year infliximab therapy in pediatric patients with Crohn's disease? Folia Medica Cracoviensia 57(2): 63-71
Bianchi, A.T.; Zwart, R.J.; Van der Heijden, P.J. 1990: Induction of an enteric Ig-response against ovalbumin and stimulation of the response by cholera toxin and its B-subunit in mice Regional Immunology 3(3): 131-138
Pachot, A.; Arnaud, Béatrice.; Marrote, H.; Cazalis, M-Angélique.; Diasparra, J.; Gouraud, A.; Mougin, B.; Miossec, P. 2007: Increased tumor necrosis factor-alpha mRNA expression in whole blood from patients with rheumatoid arthritis: reduction after infliximab treatment does not predict response Journal of Rheumatology 34(11): 2158-2161
Westhovens, Ré.; Houssiau, Fédéric.; Joly, J.; Everitt, D.E.; Zhu, Y.; Sisco, D.; Van Hartingsveldt, B.; Mascelli, M.Ann.; Graham, M.A.; Durez, P.; Bouman-Thio, E. 2006: A phase I study assessing the safety, clinical response, and pharmacokinetics of an experimental infliximab formulation for subcutaneous or intramuscular administration in patients with rheumatoid arthritis Journal of Rheumatology 33(5): 847-853
Kalb, R.E.; Blauvelt, A.; Sofen, H.L.; Chevrier, M.; Amato, D.; Calabro, S.; Wang, J.; Schenkel, B.; Gottlieb, A.B. 2013: Effect of infliximab on health-related quality of life and disease activity by body region in patients with moderate-to-severe psoriasis and inadequate response to etanercept: results from the PSUNRISE trial Journal of Drugs in Dermatology: Jdd 12(8): 874-880
Heldmann, F.; Brandt, J.; van der Horst-Bruinsma, I.E.; Landewe, R.; Sieper, J.; Burmester, G.R.; van den Bosch, F.; de Vlam, K.; Geusens, P.; Gaston, H.; Schewe, S.; Appelboom, T.; Emery, P.; Dougados, M.; Leirisalo-Repo, M.; Breban, M.; Listing, J.; Braun, J. 2011: The European ankylosing spondylitis infliximab cohort (EASIC): a European multicentre study of long term outcomes in patients with ankylosing spondylitis treated with infliximab Clinical and Experimental Rheumatology 29(4): 672-680
Kaulen, D.R.; Maslova, T.N.; Pershin, S.B. 1977: Induction of the immunologic response in vitro Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 11: 106-111
Yoshida, K. 2008: Mechanisms for induction of apoptosis in response to DNA damage SEIKAGAKU. Journal of Japanese Biochemical Society 80(7): 619-631
Anshina, M.B.; Zdanovskiĭ, V.M.; Kechiian, K.N.; Solomatina, E.V.; Vartikian, K.S. 1991: Evaluation of ovarian response in ovulation induction Akusherstvo i Ginekologiia 3: 50-53
Sterzl, J. 1988: Processing and presentation of antigens as a part of the induction of the immune response Bratislavske Lekarske Listy 89(6): 403-414